Details of the Drug Formulaction

General Information of Drug Formulation (ID: F02504)

• Formulation Name: Betrixaban 40 mg capsule
• Company: Portola Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
BETRIXABAN	(DM2C4RF)	Venous thromboembolism	BD72	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Dextrose monohydrate	(E00538)	22814120	Binding agent; Diluent; Flavoring agent; Tonicity agent
FD&C blue no. 1	(E00263)	19700	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent